Immunology Scientist - Small Molecule Drug Discovery

Initial Therapeutics, Inc.; Monrovia (CA); On-site; USD 120,000 - 175,000; Full time

Benefits offered by this job

Health, dental, and vision insurance

401k with a 3% safe harbor contribution

Stock option plan

Job summary

Initial Therapeutics, Inc. in Monrovia, CA, is seeking an experienced immunologist to join their cell assay team. This full-time role involves designing experiments and optimizing assays to support drug discovery efforts. Candidates must have a strong background in immunology and extensive experience with cellular techniques.

The position offers a competitive salary ranging from $120,000 to $175,000 annually, alongside substantial benefits including health, dental, and vision insurance, stock options, and a retirement plan. Join a rapidly growing biotech at the forefront of drug development.

Qualifications

• Strong background in immunology and immune signaling pathways.
• Extensive hands-on experience with cell culture and cellular assays.
• Proficiency in primary cell isolation and differentiation.

Responsibilities

• Design experiments to confirm mechanisms of action.
• Independently develop and optimize cell-based assays.
• Manage CROs for reagent development and testing.

Skills

Immunology

Cell culture

Flow cytometry

Data analysis

Education

PhD in immunology or related field

MSc with extensive experience

Tools

qPCR

RNAseq

ELISA

Luminex

Job description

Initial Therapeutics, Inc. in Monrovia, CA, is seeking an experienced immunologist to join their cell assay team. This full-time role involves designing experiments and optimizing assays to support drug discovery efforts. Candidates must have a strong background in immunology and extensive experience with cellular techniques.

The position offers a competitive salary ranging from $120,000 to $175,000 annually, alongside substantial benefits including health, dental, and vision insurance, stock options, and a retirement plan. Join a rapidly growing biotech at the forefront of drug development.